BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9125248)

  • 1. Characteristic epitope recognition pattern of autoantibodies against eukaryotic ribosomal protein L7 in systemic autoimmune diseases.
    Neu E; Hemmerich PH; Peter HH; Krawinkel U; von Mikecz AH
    Arthritis Rheum; 1997 Apr; 40(4):661-71. PubMed ID: 9125248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of eukaryotic protein L7 as a novel autoantigen which frequently elicits an immune response in patients suffering from systemic autoimmune disease.
    von Mikecz A; Hemmerich P; Peter HH; Krawinkel U
    Immunobiology; 1994 Dec; 192(1-2):137-54. PubMed ID: 7750987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.
    Tzioufas AG; Tzortzakis NG; Panou-Pomonis E; Boki KA; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Ann Rheum Dis; 2000 Feb; 59(2):99-104. PubMed ID: 10666163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies against eukaryotic protein L7 in patients suffering from systemic lupus erythematosus and progressive systemic sclerosis: frequency and correlation with clinical, serological and genetic parameters. The SLE Study Group.
    Neu E; von Mikecz AH; Hemmerich PH; Peter HH; Fricke M; Deicher H; Genth E; Krawinkel U
    Clin Exp Immunol; 1995 May; 100(2):198-204. PubMed ID: 7743655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating anticentromere CENP-A and CENP-B antibodies in patients with diffuse and limited systemic sclerosis, systemic lupus erythematosus, and rheumatoid arthritis.
    Russo K; Hoch S; Dima C; Varga J; Teodorescu M
    J Rheumatol; 2000 Jan; 27(1):142-8. PubMed ID: 10648030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramolecular epitope spreading among anti-caspase-8 autoantibodies in patients with silicosis, systemic sclerosis and systemic lupus erythematosus, as well as in healthy individuals.
    Ueki A; Isozaki Y; Tomokuni A; Hatayama T; Ueki H; Kusaka M; Shiwa M; Arikuni H; Takeshita T; Morimoto K
    Clin Exp Immunol; 2002 Sep; 129(3):556-61. PubMed ID: 12197899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
    Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
    Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential recognition of the phosphorylated major linear B-cell epitope of La/SSB 349-368 aa by anti-La/SSB autoantibodies from patients with systemic autoimmune diseases.
    Terzoglou AG; Routsias JG; Avrameas S; Moutsopoulos HM; Tzioufas AG
    Clin Exp Immunol; 2006 Jun; 144(3):432-9. PubMed ID: 16734612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Ephrin Type-B Receptor 2 (EphB2) and Anti-Three Prime Histone mRNA EXonuclease 1 (THEX1) Autoantibodies in Scleroderma and Lupus.
    Azzouz DF; Martin GV; Arnoux F; Balandraud N; Martin T; Dubucquoi S; Hachulla E; Farge-Bancel D; Tiev K; Cabane J; Bardin N; Chiche L; Martin M; Caillet EC; Kanaan SB; Harlé JR; Granel B; Diot E; Roudier J; Auger I; Lambert NC
    PLoS One; 2016; 11(9):e0160283. PubMed ID: 27617966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantigenic epitopes on eukaryotic L7.
    von Mikecz AH; Hemmerich PH; Peter HH; Krawinkel U
    Clin Exp Immunol; 1995 May; 100(2):205-13. PubMed ID: 7743656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
    Kuwana M; Kimura K; Kawakami Y
    Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins.
    Mahler M; Kessenbrock K; Raats J; Williams R; Fritzler MJ; Blüthner M
    J Mol Med (Berl); 2003 Mar; 81(3):194-204. PubMed ID: 12682728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
    Mahler M; Fritzler MJ; Blüthner M
    Arthritis Res Ther; 2005; 7(1):R19-29. PubMed ID: 15642139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to ribonucleic acids detected by ELISA in systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis.
    Costa O; Pinatel K; Monier JC
    J Rheumatol; 1985 Oct; 12(5):928-33. PubMed ID: 2418204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope-specific recognition of type II collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse.
    Burkhardt H; Koller T; Engström A; Nandakumar KS; Turnay J; Kraetsch HG; Kalden JR; Holmdahl R
    Arthritis Rheum; 2002 Sep; 46(9):2339-48. PubMed ID: 12355481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3.
    Recke A; Regensburger AK; Weigold F; Müller A; Heidecke H; Marschner G; Hammers CM; Ludwig RJ; Riemekasten G
    Front Immunol; 2018; 9():428. PubMed ID: 29623076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique epitopes for carbonic anhydrase II autoantibodies related to autoimmune retinopathy and cancer-associated retinopathy.
    Adamus G; Yang S; Weleber RG
    Exp Eye Res; 2016 Jun; 147():161-168. PubMed ID: 27185162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-A2/RA33 autoantibodies are directed to the RNA binding region of the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. Differential epitope recognition in rheumatoid arthritis, systemic lupus erythematosus, and mixed connective tissue disease.
    Skriner K; Sommergruber WH; Tremmel V; Fischer I; Barta A; Smolen JS; Steiner G
    J Clin Invest; 1997 Jul; 100(1):127-35. PubMed ID: 9202064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiribonuclease H2 antibodies are an immune biomarker for systemic lupus erythematosus.
    Nozawa K; Doe K; Uomori K; Sekigawa I; Takasaki Y; Yamaji K; Tamura N
    Autoimmunity; 2017 Jun; 50(4):241-246. PubMed ID: 28553742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.